An interventional study of 1-week nicotine replacement therapy sampling and Brief cessation advice in Tobacco Smoking, sponsored by The University of Hong Kong. Status unknown at 1 site in Hong Kong. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-07-11.
Sponsored by The University of Hong Kong · Not applicable, Interventional, and Treatment
The aim of this clinical trial is to test the effectiveness of 1-week nicotine replacement therapy sampling delivered by lay counsellors in promoting smoking cessation in smokers in the community.
81 studies on the registry are indexed under Tobacco Smoking; 27 are open to participants now.
This study's planned enrollment of 1,014 is above the median of 120 across 69 interventional studies indexed under Tobacco Smoking.
Browse Tobacco Smoking studies →The University of Hong Kong is the lead sponsor of 1,286 studies on the registry; 343 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
1-week nicotine replacement therapy sample + Brief cessation advice
Behavioral: 1-week nicotine replacement therapy sampling · Behavioral: Brief cessation advice
Brief cessation advice
Behavioral: Brief cessation advice
Participants will be given an 1-week sample of nicotine replacement therapy (patch or gum) with brief instructions on how to use the product
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model: A: Ask about the tobacco use status; W: Warn about the hazards of tobacco use; A: Advise the smokers to quit; R: Refer the smokers to cessation services; D: Do-it-again
Biochemically validated tobacco abstinence
Verified by a negative salivary cotinine test
Time frame: 6 months
Biochemically validated tobacco abstinence
Verified by a negative salivary cotinine test
Time frame: 3 months
Self-reported 7-day point-prevalence tobacco abstinence
Time frame: 3 months
Self-reported 7-day point-prevalence tobacco abstinence
Time frame: 6 months
Self-reported 24-hour quit attempt
Time frame: 3 months
Self-reported 24-hour quit attempt
Time frame: 6 months
Self-reported use of nicotine replacement therapy product
Time frame: 3 months
Self-reported use of nicotine replacement therapy product
Time frame: 6 months
Self-reported use of smoking cessation service
Time frame: 3 months
Self-reported use of smoking cessation service
Time frame: 6 months
Self-reported reduction of tobacco consumption
Smoking reduction by at least half of the baseline daily number of cigarettes
Time frame: 3 months
Self-reported reduction of tobacco consumption
Smoking reduction by at least half of the baseline daily number of cigarettes
Time frame: 6 months
Change in motivation to quit from baseline through 3-month follow-up
Time frame: 3 months
Change in motivation to quit from baseline through 6-month follow-up
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.